We remain committed to ensuring the safety and wellbeing of your patients and will continue to partner with you to help support them.
While there is more to be done, we are making steady progress. We ramped up production capacity and have devices available for those who need them. We are also continuing our extensive test and research program.
Your patients have several options for remediation which include payment, continue to wait for a new or refurbished device, or opt for an auto-adjusting CPAP.
If your patients chose an Auto-adjusting CPAP device from Philips Respironics, you may receive questions concerning their treatment to make sure that an auto-CPAP is appropriate for their condition.
The tests, conducted together with five independent, certified testing laboratories and assessed by third- party qualified experts and Philips Respironics, as well as an external panel of experts, have now been completed and risk assessments evaluated for all home sleep therapy devices.
February 13, 2023
Click here to learn more(Emergency Use Authorization)
Also known as DreamStation BiPAP autoSV
Also known as DreamStation BiPAP AVAPS, DreamStation BiPAP S/T
Also known as System One BiPAP autoSV, System One BiPAP autoSV Advanced
Also known as System One BiPAP AVAPS (C-Series), System One BiPAP S/T (C-Series)
In-Lab Titration Device
Also known as BiPAP Hybrid A30Ventilator (A-Series)
(not marketed in US)
Also known as BiPAP V30 Auto Ventilator (A-Series)
Also known as BiPAP A40 Ventilator (A-Series)
(not marketed in US)
Also known as BiPAP A30 Ventilator (A-Series)
(not marketed in US)
If your device is affected...
Products that are not affected may have different sound abatement foam materials, as new materials and technologies are available over time. Also, sound abatement foam in unaffected devices may be placed in a different location due to device design.
You are about to visit a Philips global content page
Continue